Historical Shareholders 

Since 1997, the company has raised € 47 M in three rounds. Large investors are Venture Capitalists. They comprise: Advent Management, Alafi Capital, Apax Partners, Auriga Partners, Banexi Venture Partners, HealthCap, Avida Group, Kimed, Life Sciences Partners, Lombard Odier, Medicis, La Compagnie Financière Edmond de Rothschild andRendex Partners.

  Advent Management (www.advent.be)

Advent Management Belgium is one of the most prominent private equity investors in Belgium. Advent manages the independent Sofindev funds that provide expansion financing or replacement capital.

  Alafi Capital

Alafi Capital is a private venture capital company mainly specialized in life sciences market, investing primarily in the USA but also in several European countries. Alafi Capital ususually invest at very early stage, and maintains its investment in Companies up stock-market listing and beyond. The track record of Alafi Capital is probably one of the best in the world, having been at the origin of several of todays industrial leaders in Biotechnology, including Amgen, Biogen, Cetus (now part of Chiron), Cooley Pharmaceuticals, Genelabs, Molecular Devices, Molecular Dynamics, , Oxford Glycosciences (UK) Qiagen (Germany) etc…

  Apax Partners (www.apax.com)

Apax Partners is one of the world's leading private equity investment firms. Apax is dedicated to helping entrepreneurs build world class companies. The company track record of working with entrepreneurs from start up to leveraged transactions of over Euro 1 billion is exceptional. Since 1995 alone 46 of their companies went public on stock markets around the world. At point of entry to market these companies had a collective market capitalisation of over Euro 23 billion. Apax Partners currently has Euro 12 billion under management or advice around the world, and 330 companies in the portfolio. Apax 160 investment professionals operate from twelve offices in nine countries.

  Auriga Partner's (www.aurigapartners.com)

Auriga Partners, a Portfolio Management Company owned outright by the managing partners, was founded in July 1998. The team consists of 6 professionals, who collectively have experience in venture capital. The team manages the AURIGA VENTURES, whose first investments were made at the beginning of 1999. Auriga also manages the EUROPEAN MEDICAL VENTURES Fund (EMV) which was set up in 1993 and is now fully invested.

  Avida Group (www.avida-group.com)

AVIDA Group is an independent private equity management group that manages and supports pan-European private equity funds with aggregate capital commitments amounting to more than EUR 460 million. In addition to initiating and managing its own private equity funds, AVIDA Group is specialized in Secondary Management and Private Equity Advisory.

  HealthCap (www.healthcap.se)

HealthCap is a family of venture capital funds managed by the Odlander Fredrikson Group. With committed capital exceeding MSEK 2,800. HealthCap is the largest specialized provider of venture capital within life sciences in the Nordic countries and one of the largest independent actors in the sector in Europe.

  Kimed

Kimed is a german-based private equity found.

  Life Sciences Partners (www.lsp.nl)

Life Sciences Partners is a European venture capital firm based in Amsterdam (Netherlands) and Munich (Germany), focusing on human biotechnology and medical devices. The fund has € 170 million capital under management and has invested in a broad range of companies in Europe, the US and Israel. The partners of the fund have a proven track record in venture capital and the life sciences, among others through Board Seats at listed companies as Qiagen, Quadrant, Rhein Biotech, Biora and Crucell.

  Lombard Odier (www.lombardodier.ch)

With 16 offices and a staff of more than 1,400 worldwide, the Lombard Odier Group is truly international and boasts unrivaled expertise in all of the world's major financial centers.

  Medicis KG (www.medicis.de)

Medicis provides venture capital to innovative teams and companies in the Life Science and Healthcare market. Their mission is to provide their market know how as well as their distinctive financial and business network to young and innovative companies employing cutting edge life science technologies or novel health care management concepts and/or systems. Jointly with their portfolio companies they strive to improve the quality and efficiency of the life science and healthcare market.

  La Compagnie Financière Edmond de Rothschild (www.lcf-rothschild.fr)

La Compagnie Financière Edmond de Rothschild has a 15 years expertise in private equity services to help geographical, commercial, technological or industrial development of private companies. Such activities are linked to an adequate appreciation of the company's projects, not only on technical aspects but also on management's objectives. It consists in a strong knowledge of financial tools in order to ensure a high remuneration to investors while motivating management team.

  Rendex Partners (www.rendex.com)

Rendex Partners is a European based private equity fund, managing Rendex Fund, a venture capital fund investing in growth opportunities in industry ranging from high tech to no-tech.